HPV Infection and Cervical Cancer Prevention

Author and Disclosure Information

Although accreditation for this CE/CME activity has expired, and the posttest is no longer available, you can still read the full article.

Expires September 30, 2014

Improved understanding of the central role of human papillomavirus (HPV) in cervical carcinogenesis has led to the development of vaccines and DNA testing for high-risk HPV subtypes. But age-appropriate cytologic screening remains the cornerstone in the prevention and early detection of cervical intraepithelial neoplasia (CIN) and cervical cancer. With prompt diagnosis and treatment of both CIN and early-stage cervical cancer, the prognosis for this disease is excellent.



CE/CME No: CR-1309

Earn credit by reading this article and successfully completing the posttest. Successful completion is defined as a cumulative score of at least 70% correct.

• Discuss the central role that human papillomavirus (HPV) infection plays in the development of cervical intraepithelial neoplasia (CIN) and cervical cancer.
• Instruct patients on contributing cofactors of HPV infection and cervical cancer, including tobacco use, parity, use of oral contraceptives, co-infection with HIV, and immunosuppression.
• Describe the current recommendations for cervical cancer screening from professional societies, national health organizations, and federal agencies, including age-appropriate screening for cytology and high-risk HPV.
• Explain the timing and administration schedules of the currently available HPV vaccines and the patient populations for which the vaccines have been approved.
• Discuss the ablative and excisional procedures used to treat CIN and the treatment options for cervical cancer.

Heather P. Adams is an Assistant Professor/Clinical Coordinator in the Physician Assistant Program at Gannon University in Erie, Pennsylvania; in the program, Erica L. Carnright is a Physician Assistant student on clinical rotations.

The authors have no significant financial relationships to disclose.


This program has been reviewed and is approved for a maximum of 1.0 hour of American Academy of Physician Assistants (AAPA) Category I CME credit by the Physician Assistant Review Panel. [NPs: Both ANCC and the AANP Certification Program recognize AAPA as an approved provider of Category 1 credit.] Approval is valid for one year from the issue date of September 2013.

Article begins on next page >>


Next Article: